Brenda F Kahl

Title: Brenda F. Kahl: Innovator in Gene Expression Monitoring

Introduction

Brenda F. Kahl is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of gene expression monitoring. With a total of 2 patents, her work has advanced the methodologies used in nucleic acid hybridization assays, particularly through the use of microelectronic arrays.

Latest Patents

Brenda's latest patents include innovative techniques for quantitative analysis methods on active electronic microarrays. This invention presents methods that are particularly useful for gene expression monitoring and other nucleic acid hybridization assays. The techniques utilize microelectronic arrays to facilitate the transport and hybridization of nucleic acids, providing methods for normalizing signals of individual microlocations using an internal control sequence probe.

Another notable patent focuses on methods for gene expression monitoring on electronic microarrays. This invention describes procedures for generating mRNA expression samples from various biological materials, which may differ in their physiological and pathological states. The methods allow for the creation of a reusable nucleic acid transcript library from mRNA, enhancing gene expression monitoring on microelectronic arrays. The invention also includes methods for detecting sample amplicons using electronically assisted primer extension detection, which aids in correlating changes in mRNA levels with the expression of encoded proteins in biological materials.

Career Highlights

Brenda F. Kahl has made significant strides in her career, particularly through her work at Nanogen, Inc. Her innovative approaches have positioned her as a leader in the field of molecular biology and biotechnology.

Collaborations

Brenda has collaborated with notable coworkers, including Ling Wang and Xiao Xu, contributing to the advancement of research in gene expression and hybridization methodologies.

Conclusion

Brenda F. Kahl's contributions to gene expression monitoring through her patents and work at Nanogen, Inc. highlight her role as a key innovator in biotechnology. Her advancements in microelectronic arrays continue to influence the field significantly.